Clinical Trials › NCT05359653
RecruitingPhase 1
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
Sponsored by University of California, San Francisco
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 74
Target enrollment
1
U.S. states
Aug 2023
Start date
Jun 2026
Expected completion
Interventions / Treatments
Clemastine FumaratePlacebo
Conditions studied
Multiple Sclerosis (MS)Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Chronic ProgressiveMultiple Sclerosis RelapseMultiple Sclerosis Brain LesionMultiple Sclerosis Benign
Where this trial is running (1 site)
California1 site
San Francisco
Participating MS centers on MS Buddy (1)
UCSF Multiple Sclerosis Center
San Francisco, CA
San Francisco, CA
MS centers in California
Compare treatment centers near a trial site by center type, providers and trials.
View California centersMore Phase 1 trials
Browse all Phase 1 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.